Literature DB >> 14980170

[Knowledge of hormone replacement therapy among menopausal women].

Isabel Ruiz1, María José Bermejo.   

Abstract

OBJECTIVES: To analyze the information that women have on hormone replacement therapy (HRT), the sources of this information and how it is related to prescription.
METHODS: We performed a cross-sectional study through a telephone survey. Information was collected on prescription of HRT, knowledge of HRT and of its health benefits, risks and type of risk, and sources of information.
RESULTS: 371 interviews (80% of the original sample) were completed. 66% of the sample reported knowledge of the benefits of HRT and 42% learnt of them from health professionals. 36% thought that HRT could pose health risks. 91% of the women prescribed this treatment reported knowledge of its benefits compared with 57% of those not prescribed it (OR = 7.32; 95% CI, 2.86-18.74). Health professionals were the main source of information about these benefits among women prescribed HRT (93%) (OR = 83,47; 95% CI, 26.83-278.63). 57% of the women prescribed HRT reported knowledge of its risks compared with 28% of those not prescribed this therapy (OR = 3.11; 95% CI, 1.59-6.05).
CONCLUSIONS: Women prescribed HRT were better informed than those not prescribed this therapy. Among users, more than 90% mentioned some benefits, but 43% reported not knowing about its risks. Information on the benefits of HRT was mainly provided by health professionals whereas information on the risks was provided by both health professionals and the mass media.

Entities:  

Mesh:

Year:  2004        PMID: 14980170     DOI: 10.1016/s0213-9111(04)71996-2

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  2 in total

1.  [Knowledge of the menopause in women 30-60 years old in the Vigo (Spain) Health Area].

Authors:  Maria José Puialto-Durán; Laura Moure-Fernández; Carlos Salgado-Álvarez; Rosa Antolín-Rodríguez
Journal:  Aten Primaria       Date:  2010-08-03       Impact factor: 1.137

2.  SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media.

Authors:  A Einarson; A K Schachtschneider; R Halil; E Bollano; G Koren
Journal:  BMC Pregnancy Childbirth       Date:  2005-05-20       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.